82 related articles for article (PubMed ID: 8123940)
1. Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cells.
Baker WJ; Maenpaa JU; Wurz GT; Koester SK; Seymour RC; Emshoff VD; Wiebe VJ; DeGregorio MW
Oncol Res; 1993; 5(6-7):207-12. PubMed ID: 8123940
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cells.
Baker WJ; Wiebe VJ; Koester SK; Emshoff VD; Maenpaa JU; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 1992; 24(1):43-9. PubMed ID: 1463871
[TBL] [Abstract][Full Text] [Related]
3. [Toremifene sensitized the effect of adriamycin on human breast cancer cell lines].
Nakagomi H; Furuya K; Hagiwara J; Nishio T; Watanabe K; Muto S; Takano K; Tada Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():454-8. PubMed ID: 9589052
[TBL] [Abstract][Full Text] [Related]
4. Effects of toremifene and its main metabolites on growth of breast cancer cell lines.
Coradini D; Biffi A; Cappelletti V; Di Fronzo G
Anticancer Res; 1991; 11(6):2191-7. PubMed ID: 1837981
[TBL] [Abstract][Full Text] [Related]
5. [Combined effects of toremifene and paclitaxel on human breast cancer cell lines].
Maruyama S; Kuroiwa S; Saimoto A; Nishikawa K
Gan To Kagaku Ryoho; 2003 May; 30(5):669-75. PubMed ID: 12795099
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry: potential utility in monitoring drug effects in breast cancer.
Koester SK; Maenpaa JU; Wiebe VJ; Baker WJ; Wurz GT; Seymour RC; Koehler RE; DeGregorio MW
Breast Cancer Res Treat; 1994; 32(1):57-65. PubMed ID: 7819587
[TBL] [Abstract][Full Text] [Related]
7. [The in vitro combination-effect of toremifene with CAF (cyclophosphamide, adriamycin, 5-fluorouracil) on growth of various human mammary carcinomas].
Kuroiwa S; Maruyama S; Okada M; Abe F
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1581-9. PubMed ID: 9725052
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
10. [Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].
Zhang X; Li Q; Han Y; Liu Z
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):537-9. PubMed ID: 12667319
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
Somers-Edgar TJ; Rosengren RJ
Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
[TBL] [Abstract][Full Text] [Related]
12. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
13. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
14. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells.
Balabhadrapathruni S; Thomas TJ; Yurkow EJ; Amenta PS; Thomas T
Oncol Rep; 2000; 7(1):3-12. PubMed ID: 10601582
[TBL] [Abstract][Full Text] [Related]
15. Toremifene and its metabolites enhance doxorubicin accumulation in estrogen receptor negative multidrug resistant human breast cancer cells.
Wiebe V; Koester S; Lindberg M; Emshoff V; Baker J; Wurz G; DeGregorio M
Invest New Drugs; 1992 Jul; 10(2):63-71. PubMed ID: 1386843
[TBL] [Abstract][Full Text] [Related]
16. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
Han GZ; Liu ZJ; Shimoi K; Zhu BT
Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
[TBL] [Abstract][Full Text] [Related]
17. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
19. Effects of tamoxifen and the derivative (TAT) on cell cycle of MCF-7 in vitro.
Tominaga T; Yoshida Y; Matsumoto A; Hayashi K; Kosaki G
Anticancer Res; 1993; 13(3):661-5. PubMed ID: 8317894
[TBL] [Abstract][Full Text] [Related]
20. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
